Letter to the editor on the paper: "The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing"

MS Treatments

Jahr

Publikationsjahr
2018

Autoren

Autorenliste der Publikation
Sehr T, Proschmann U, Thomas K, Ziemssen T.

Verlag

Publisher-Information
Mult Scler J 2018;24(6):820-822.

Link

Zur Publikation (externer Server)
https://doi.org/10.1177/1352458517726384

Tags

Forschungsthemen
Multiple SkleroseMS Behandlung
MSZTreatments2018